Bone marrow disease. Multiple myeloma and malignant plasma cell neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18-55 years Conscious consent to enter the study BMI 18-25
Exclusion criteria
Exclusion criteria: Mental retardation Generalized anxiety disorder Major Depressive Disorder Pregnancy Lactation Drug addiction Take analgesic less than 4 hours before admission Hypersensitivity to apotel, promethazine and lidocaine GFR < 30 Cirrhosis Child B & C
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of pain during bone marrow biopsy and aspiration. Timepoint: Immediately after completing the procedure and 30 minutes later in the intervention and control groups. Method of measurement: To estimate the severity of pain and the effect of the drug in relieving the patient's pain from the quantitative scale VAS(Visual Analog Scale) is used.;Anxiety after completing the procedure. Timepoint: After the procedure and 30 minutes later, the patient's anxiety is rated from 1 to 10, depending on the severity. Method of measurement: Anxiety severity is divided from zero to ten using a questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences